Liposic 2mg/g Eye Gel

  • Name:

    Liposic 2mg/g Eye Gel

  • Company:
    info
  • Active Ingredients:

    Carbomer

  • Legal Category:

    Supply through pharmacy only

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 21/05/18

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 19/6/2019

Click on this link to Download PDF directly

Bausch Health Ireland Ltd.

Bausch & Lomb U

Company Products

Medicine NameActive Ingredients
Medicine Name Artelac, Eye drops solution Active Ingredients Hypromellose
Medicine Name Artelac, SDU, Eye drops solution Active Ingredients Hypromellose
Medicine Name Emerade, 150 micrograms, solution for injection in pre-filled pen Active Ingredients Adrenaline tartrate
Medicine Name Emerade, 300 micrograms, solution for injection in pre-filled pen Active Ingredients Adrenaline tartrate
Medicine Name Emerade, 500 micrograms, solution for injection in pre-filled pen Active Ingredients Adrenaline tartrate
Medicine Name Emerade, solution for injection in pre-filled pen Active Ingredients Adrenaline tartrate
Medicine Name GelTears, Eye Gel Active Ingredients Carbomer
Medicine Name Liposic 2mg/g Eye Gel Active Ingredients Carbomer
Medicine Name Lotemax 0.5% Eye Drops, Suspension Active Ingredients Loteprednol Etabonate
Medicine Name Minims Artificial Tears, Eye drops solution Active Ingredients Hyetellose, Sodium Chloride
Medicine Name Minims Atropine Sulphate 1%w/v, Eye drops solution Active Ingredients Atropine sulfate
Medicine Name Minims Chloramphenicol 0.5% w/v, Eye drops solution Active Ingredients Chloramphenicol
Medicine Name Minims Cyclopentolate Hydrochloride 1.0% w/v, Eye drops solution Active Ingredients Cyclopentolate Hydrochloride
Medicine Name Minims Fluorescein sodium 1% & 2% w/v Active Ingredients Fluorescein Sodium
Medicine Name Minims Fluorescein Sodium 1%, Eye drops solution Active Ingredients Fluorescein Sodium
Medicine Name Minims Fluorescein Sodium 2%, Eye drops solution Active Ingredients Fluorescein Sodium
Medicine Name Minims Lidocaine & Fluorescein. Active Ingredients Fluorescein Sodium, Lidocaine Hydrochloride
Medicine Name Minims Oxybuprocaine Hydrochloride 0.4% w/v eye drop solution Active Ingredients Oxybuprocaine Hydrochloride
Medicine Name Minims Phenylephrine Hydrochloride 10%, Eye drops solution Active Ingredients Phenylephrine Hydrochloride
Medicine Name Minims Phenylephrine Hydrochloride 2.5% & 10% w/v, Eye drops solution Active Ingredients Phenylephrine Hydrochloride
Medicine Name Minims Phenylephrine Hydrochloride 2.5%, Eye drops solution Active Ingredients Phenylephrine Hydrochloride
Medicine Name Minims Pilocarpine Nitrate 2% w/v, Eye drops solution Active Ingredients Pilocarpine nitrate
Medicine Name Minims Povidone Iodine 5% w/v eye drops, solution Active Ingredients Povidone Iodine
Medicine Name Minims Prednisolone Sodium Phosphate 0.5% Active Ingredients Prednisolone Sodium Phosphate
Medicine Name Minims Proxymetacaine 0.5% w/v, Eye Drops Solution Active Ingredients Proxymetacaine hydrochloride
1 - 0 of 36 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 19 June 2019 SmPC

Reasons for updating

  • Change to MA holder contact details

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Change of MAH

Updated on 6 June 2018 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Supply through pharmacy only

Updated on 21 May 2018 PIL

Reasons for updating

  • Change to section 6 - what the product contains

Updated on 27 February 2017 PIL

Reasons for updating

  • Change to section 2 - excipient warnings
  • Change to section 3 - use in children/adolescents
  • Change to section 6 - date of revision

Updated on 27 February 2017 SmPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

IB/C.I.3 z       Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet of human medicinal products intended to implement the outcome of a procedure concerning PSUR or PASS, or the outcome of the assessment done by the competent authority under Articles 45 or 46 of Regulation 1901/2006

Updated on 27 February 2017 PIL

Reasons for updating

  • New PIL for new product

Updated on 22 June 2016 PIL

Reasons for updating

  • Change to packaging
  • Change of manufacturer
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to instructions about missed dose
  • Change to storage instructions
  • Change to side-effects
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to how the medicine works
  • Change to further information section
  • Change to date of revision

Updated on 6 October 2015 SmPC

Reasons for updating

  • New SPC for medicines.ie

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

None provided

Updated on 31 August 2012 PIL

Reasons for updating

  • New PIL for medicines.ie